Search results
Results from the WOW.Com Content Network
South Africa's Medicines and Related Substance 1997 is a law enacted a compulsory license in order to fight HIV/AIDS epidemic. The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency.
Rational scale to assess the harm of drugs. Substance abuse prevention, also known as drug abuse prevention, is a process that attempts to prevent the onset of substance use or limit the development of problems associated with using psychoactive substances. Prevention efforts may focus on the individual or their surroundings.
The South African Health Products Regulatory Authority (SAHPRA) is the organisation in charge of regulating the use of all Health Products throughout the country. It is part of the National Department of Health .
Zolelwa Sifumba, a South African doctor, was diagnosed with drug-resistant TB in 2012 when she was a medical student and endured 18 months of treatment taking about 20 pills every day in addition ...
The world of counterfeit drugs is shady yet ubiquitous. All kinds of medicines have been counterfeited, from cancer drugs to antihistamines. And thanks to the Internet, consumers and ...
In women, injecting drugs contributed to 19% of HIV cases. No data was available for gender-nonconforming people. Harm reduction expert: Lowering barriers to safe supplies 'vital' for stigmatized ...
The drug policy is in contrast to the reduction of drug supply, but the two policies are often implemented together. Some discussions of demand reduction make a distinction between policies that address single issues (such as public "knowledge-of-harms") or are short-term interventions(in-school programs), and those that approach drug demand as ...
[3] [4] Across Africa it is estimated that only 3% of required drugs are produced, [5] with medicines not readily available during health emergencies. [6] The roughly 375 medicine manufacturers on the continent produce only 10-30% of drugs used in Africa. [7] Another challenge is the proliferation of substandard and counterfeit medical products ...